Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Natera Launches TEODOR Trial to Personalize Breast Cancer Treatment Without Chemotherapy
Date 01 August 2025

Natera Launches TEODOR Trial to Personalize Breast Cancer Treatment Without Chemotherapy

Natera Introduces ABCSG 61’s TEODOR Trial Announcement Natera Inc., a well-known leader in cell-free DNA and precision medicine, has begun a new TEODOR trial, a neoadjuvant treatment optim...

4 Biotech Companies Making Big Moves in Drug Development
Date 01 August 2025

4 Biotech Companies Making Big Moves in Drug Development

Four Biotech Companies Standing Strong Against Market Waves A Drug Struggles Through Clinical Trials A drug typically takes around 10 to 15 years to undergo clinical trials, and after completing...

Benecard and DecisionRX Partner to Improve Pharmacy Benefits with Personalized Medication Insights
Date 01 August 2025

Benecard and DecisionRX Partner to Improve Pharmacy Benefits with Personalized Medication Insights

Benecard and DecisionRX Formed a Partnership to Enhance Pharmacy Benefits Announcement DecisionRX, Inc., a key player in medication therapy optimization (MTO), and Benecard PBF, the original pha...

Kedrion's COAGADEX® Gets FDA Orphan Drug Status for Rare Bleeding Disorder
Date 01 August 2025

Kedrion's COAGADEX® Gets FDA Orphan Drug Status for Rare Bleeding Disorder

Kedrion’s COAGADEX® Received Confirmation of ‘Orphan Drug Designation' Announcement Kedrion Biopharma’s COAGADEX is now declared an orphan drug designation from the US Food...

Genethon Launches Phase 3 Trial in Europe for Gene Therapy to Treat Duchenne Muscular Dystrophy
Date 31 July 2025

Genethon Launches Phase 3 Trial in Europe for Gene Therapy to Treat Duchenne Muscular Dystrophy

Genethon's New Trial in Europe for Duchenne Muscular Dystrophy Announcement Genethon, a global prominent leader in research and development in gene therapy for rare genetic diseases, received ap...

Bristol Myers Squibb and Bain Capital Launch New Biopharma Company to Target Autoimmune Diseases
Date 31 July 2025

Bristol Myers Squibb and Bain Capital Launch New Biopharma Company to Target Autoimmune Diseases

Bristol and Bain Capital’s New Company Announcement Bristol-Myers Squibb and Bain Capital together have built a new independent biopharmaceutical company. A company that will be aiming the...

Pahr Therapeutics Secures $14M to Advance Pulmonary Arterial Hypertension (PAH) Treatment
Date 31 July 2025

Pahr Therapeutics Secures $14M to Advance Pulmonary Arterial Hypertension (PAH) Treatment

Pahr Therapeutics Raises Funds to Contribute to Pulmonary Arterial Hypertension Announcement Pahr Therapeutics Inc. was financed with $14M, along with AN Venture partners, University of Tokyo Ed...

Virocell and Avencell Join Forces to Advance Off-the-Shelf CAR-T Cell Therapy
Date 31 July 2025

Virocell and Avencell Join Forces to Advance Off-the-Shelf CAR-T Cell Therapy

Virocell and Avencell Partnered to Elevate Development in Treatments Announcement Virocell biologics, a popular vector contract development and manufacturing organization (CDMO) for cell and gen...

Spear Bio Launches Ultrasensitive SPEAR Ultradetectâ„¢ to Advance Neurodegenerative Disease Research
Date 30 July 2025

Spear Bio Launches Ultrasensitive SPEAR Ultradetectâ„¢ to Advance Neurodegenerative Disease Research

Spear Bio’s New Solution to Modify Neurodegenerative Disease Research Announcement Spear Bio, a leading biotechnology company evolving homogeneous ultrasensitive immunoassay technology, ha...

Biopharma Moves Towards Holistic Alzheimer's Care After Key Drug Approvals
Date 30 July 2025

Biopharma Moves Towards Holistic Alzheimer's Care After Key Drug Approvals

The Rising Alzheimer's Disease has Led Biopharma to Enter a Holistic Treatment Era The start to look up for In the last two years, 2023 and 2024, the treatment for the first-ever disease, Alzhei...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.